ID   SPOP_HUMAN              Reviewed;         374 AA.
AC   O43791; B2R6S3; D3DTW7; Q53HJ1;
DT   30-MAY-2000, integrated into UniProtKB/Swiss-Prot.
DT   01-JUN-1998, sequence version 1.
DT   22-JUL-2015, entry version 144.
DE   RecName: Full=Speckle-type POZ protein;
DE   AltName: Full=HIB homolog 1;
DE   AltName: Full=Roadkill homolog 1;
GN   Name=SPOP;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], SUBCELLULAR LOCATION, AND TISSUE
RP   SPECIFICITY.
RX   PubMed=9414087; DOI=10.1016/S0014-5793(97)01340-9;
RA   Nagai Y., Kojima T., Muro Y., Hachiya T., Nishizawa Y.,
RA   Wakabayashi T., Hagiwara M.;
RT   "Identification of a novel nuclear speckle-type protein, SPOP.";
RL   FEBS Lett. 418:23-26(1997).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Coronary artery;
RA   Suzuki Y., Sugano S., Totoki Y., Toyoda A., Takeda T., Sakaki Y.,
RA   Tanaka A., Yokoyama S.;
RL   Submitted (APR-2005) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Cervix, and Placenta;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   FUNCTION AS AN E3 UBIQUITIN-PROTEIN LIGASE, AND INTERACTION WITH CUL3.
RX   PubMed=14528312; DOI=10.1038/ncb1056;
RA   Furukawa M., He Y.J., Borchers C., Xiong Y.;
RT   "Targeting of protein ubiquitination by BTB-Cullin 3-Roc1 ubiquitin
RT   ligases.";
RL   Nat. Cell Biol. 5:1001-1007(2003).
RN   [7]
RP   INTERACTION WITH DAXX, AND HOMODIMERIZATION.
RX   PubMed=15240113; DOI=10.1016/j.bbrc.2004.06.022;
RA   La M., Kim K., Park J., Won J., Lee J.-H., Fu Y.M., Meadows G.G.,
RA   Joe C.O.;
RT   "Daxx-mediated transcriptional repression of MMP1 gene is reversed by
RT   SPOP.";
RL   Biochem. Biophys. Res. Commun. 320:760-765(2004).
RN   [8]
RP   INTERACTION WITH BMI1, IDENTIFICATION IN A COMPLEX WITH CUL3 AND BMI1,
RP   IDENTIFICATION IN A COMPLEX WITH CUL3 AND H2AFY, SUBCELLULAR LOCATION,
RP   AND FUNCTION.
RX   PubMed=15897469; DOI=10.1073/pnas.0408918102;
RA   Hernandez-Munoz I., Lund A.H., van der Stoop P., Boutsma E.,
RA   Muijrers I., Verhoeven E., Nusinow D.A., Panning B., Marahrens Y.,
RA   van Lohuizen M.;
RT   "Stable X chromosome inactivation involves the PRC1 Polycomb complex
RT   and requires histone MACROH2A1 and the CULLIN3/SPOP ubiquitin E3
RT   ligase.";
RL   Proc. Natl. Acad. Sci. U.S.A. 102:7635-7640(2005).
RN   [9]
RP   IDENTIFICATION.
RX   PubMed=16651542; DOI=10.1242/dev.02370;
RA   Kent D., Bush E.W., Hooper J.E.;
RT   "Roadkill attenuates Hedgehog responses through degradation of Cubitus
RT   interruptus.";
RL   Development 133:2001-2010(2006).
RN   [10]
RP   IDENTIFICATION.
RX   PubMed=16740475; DOI=10.1016/j.devcel.2006.05.004;
RA   Zhang Q., Zhang L., Wang B., Ou C.-Y., Chien C.-T., Jiang J.;
RT   "A hedgehog-induced BTB protein modulates hedgehog signaling by
RT   degrading Ci/Gli transcription factor.";
RL   Dev. Cell 10:719-729(2006).
RN   [11]
RP   IDENTIFICATION IN A COMPLEX WITH CUL3 AND DAXX, AND FUNCTION.
RX   PubMed=16524876; DOI=10.1074/jbc.M600204200;
RA   Kwon J.E., La M., Oh K.H., Oh Y.M., Kim G.R., Seol J.H., Baek S.H.,
RA   Chiba T., Tanaka K., Bang O.S., Joe C.O., Chung C.H.;
RT   "BTB domain-containing speckle-type POZ protein (SPOP) serves as an
RT   adaptor of Daxx for ubiquitination by Cul3-based ubiquitin ligase.";
RL   J. Biol. Chem. 281:12664-12672(2006).
RN   [12]
RP   FUNCTION, SUBCELLULAR LOCATION, INTERACTION WITH BRMS1, AND
RP   IDENTIFICATION IN A COMPLEX WITH CUL3 AND BRMS1.
RX   PubMed=22085717; DOI=10.1016/j.bbrc.2011.10.154;
RA   Kim B., Nam H.J., Pyo K.E., Jang M.J., Kim I.S., Kim D., Boo K.,
RA   Lee S.H., Yoon J.B., Baek S.H., Kim J.H.;
RT   "Breast cancer metastasis suppressor 1 (BRMS1) is destabilized by the
RT   Cul3-SPOP E3 ubiquitin ligase complex.";
RL   Biochem. Biophys. Res. Commun. 415:720-726(2011).
RN   [13]
RP   STRUCTURE BY NMR OF 28-173.
RG   RIKEN structural genomics initiative (RSGI);
RT   "Solution structure of N-terminal domain of speckle-type POZ
RT   protein.";
RL   Submitted (NOV-2005) to the PDB data bank.
RN   [14]
RP   X-RAY CRYSTALLOGRAPHY (1.25 ANGSTROMS) OF 28-166 IN COMPLEXES WITH
RP   H2AFY AND SUBSTRATE PEPTIDES, INTERACTION WITH CUL3; H2AFY AND DAXX,
RP   SUBUNIT, FUNCTION, DOMAIN, MUTAGENESIS OF TYR-87; TYR-123; ASP-130;
RP   TRP-131; PHE-133; LEU-186; LEU-190; LEU-193 AND ILE-217, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY.
RX   PubMed=19818708; DOI=10.1016/j.molcel.2009.09.022;
RA   Zhuang M., Calabrese M.F., Liu J., Waddell M.B., Nourse A., Hammel M.,
RA   Miller D.J., Walden H., Duda D.M., Seyedin S.N., Hoggard T.,
RA   Harper J.W., White K.P., Schulman B.A.;
RT   "Structures of SPOP-substrate complexes: insights into molecular
RT   architectures of BTB-Cul3 ubiquitin ligases.";
RL   Mol. Cell 36:39-50(2009).
RN   [15]
RP   X-RAY CRYSTALLOGRAPHY (2.40 ANGSTROMS) OF 177-319 IN COMPLEX WITH
RP   CUL3, FUNCTION, INTERACTION WITH CUL3 AND H2AFY, AND SUBUNIT.
RX   PubMed=22632832; DOI=10.1016/j.str.2012.04.009;
RA   Errington W.J., Khan M.Q., Bueler S.A., Rubinstein J.L.,
RA   Chakrabartty A., Prive G.G.;
RT   "Adaptor protein self-assembly drives the control of a cullin-RING
RT   ubiquitin ligase.";
RL   Structure 20:1141-1153(2012).
CC   -!- FUNCTION: Component of a cullin-RING-based BCR (BTB-CUL3-RBX1) E3
CC       ubiquitin-protein ligase complex that mediates the ubiquitination
CC       of target proteins, leading most often to their proteasomal
CC       degradation. In complex with CUL3, involved in ubiquitination and
CC       proteasomal degradation of BRMS1, DAXX, PDX1/IPF1, GLI2 and GLI3.
CC       In complex with CUL3, involved in ubiquitination of H2AFY and
CC       BMI1; this does not lead to their proteasomal degradation.
CC       Inhibits transcriptional activation of PDX1/IPF1 targets, such as
CC       insulin, by promoting PDX1/IPF1 degradation. The cullin-RING-based
CC       BCR (BTB-CUL3-RBX1) E3 ubiquitin-protein ligase complex containing
CC       homodimeric SPOP has higher ubiquitin ligase activity than the
CC       complex that contains the heterodimer formed by SPOP and SPOPL.
CC       {ECO:0000269|PubMed:14528312, ECO:0000269|PubMed:15897469,
CC       ECO:0000269|PubMed:16524876, ECO:0000269|PubMed:19818708,
CC       ECO:0000269|PubMed:22085717, ECO:0000269|PubMed:22632832}.
CC   -!- PATHWAY: Protein modification; protein ubiquitination.
CC   -!- SUBUNIT: Interacts with GLI2 and GLI3 (By similarity). Homodimer
CC       and homooligomer. Heterodimer with SPOPL. Each dimer interacts
CC       with two CUL3 molecules. Part of cullin-RING-based BCR (BTB-CUL3-
CC       RBX1) E3 ubiquitin-protein ligase complexes that contain CUL3 and
CC       homodimeric SPOP, or the heterodimer formed by SPOP and SPOPL,
CC       plus a target protein, such as H2AFY, PDX1/IPF1, BMI1, BRMS1 and
CC       DAXX. {ECO:0000250, ECO:0000269|PubMed:14528312,
CC       ECO:0000269|PubMed:15240113, ECO:0000269|PubMed:15897469,
CC       ECO:0000269|PubMed:16524876, ECO:0000269|PubMed:19818708,
CC       ECO:0000269|PubMed:22085717, ECO:0000269|PubMed:22632832}.
CC   -!- INTERACTION:
CC       Q13618:CUL3; NbExp=2; IntAct=EBI-743549, EBI-456129;
CC       Q9UER7:DAXX; NbExp=5; IntAct=EBI-743549, EBI-77321;
CC       Q16829:DUSP7; NbExp=5; IntAct=EBI-743549, EBI-1265847;
CC       Q99836:MYD88; NbExp=6; IntAct=EBI-743549, EBI-447677;
CC       Q9Y6Q9:NCOA3; NbExp=6; IntAct=EBI-743549, EBI-81196;
CC       P60484:PTEN; NbExp=4; IntAct=EBI-743549, EBI-696162;
CC   -!- SUBCELLULAR LOCATION: Nucleus. Nucleus speckle.
CC   -!- TISSUE SPECIFICITY: Widely expressed.
CC       {ECO:0000269|PubMed:9414087}.
CC   -!- DOMAIN: The BTB (POZ) domain mediates dimerization and interaction
CC       with CUL3. {ECO:0000269|PubMed:19818708}.
CC   -!- DOMAIN: The MATH domain mediates interaction with protein-
CC       ubiquitin ligase substrates, such as H2AFY and BMI1.
CC       {ECO:0000269|PubMed:19818708}.
CC   -!- MISCELLANEOUS: Antigen recognized by serum from scleroderma
CC       patient.
CC   -!- SIMILARITY: Belongs to the Tdpoz family. {ECO:0000305}.
CC   -!- SIMILARITY: Contains 1 BTB (POZ) domain. {ECO:0000255|PROSITE-
CC       ProRule:PRU00037}.
CC   -!- SIMILARITY: Contains 1 MATH domain. {ECO:0000255|PROSITE-
CC       ProRule:PRU00129}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AJ000644; CAA04199.1; -; mRNA.
DR   EMBL; AK222589; BAD96309.1; -; mRNA.
DR   EMBL; AK312691; BAG35570.1; -; mRNA.
DR   EMBL; CH471109; EAW94671.1; -; Genomic_DNA.
DR   EMBL; CH471109; EAW94672.1; -; Genomic_DNA.
DR   EMBL; CH471109; EAW94673.1; -; Genomic_DNA.
DR   EMBL; CH471109; EAW94674.1; -; Genomic_DNA.
DR   EMBL; CH471109; EAW94675.1; -; Genomic_DNA.
DR   EMBL; BC001269; AAH01269.1; -; mRNA.
DR   EMBL; BC003385; AAH03385.1; -; mRNA.
DR   CCDS; CCDS11551.1; -.
DR   RefSeq; NP_001007227.1; NM_001007226.1.
DR   RefSeq; NP_001007228.1; NM_001007227.1.
DR   RefSeq; NP_001007229.1; NM_001007228.1.
DR   RefSeq; NP_001007230.1; NM_001007229.1.
DR   RefSeq; NP_001007231.1; NM_001007230.1.
DR   RefSeq; NP_003554.1; NM_003563.3.
DR   RefSeq; XP_005257780.1; XM_005257723.3.
DR   RefSeq; XP_005257781.1; XM_005257724.3.
DR   UniGene; Hs.463382; -.
DR   UniGene; Hs.740407; -.
DR   PDB; 2CR2; NMR; -; A=28-173.
DR   PDB; 3HQH; X-ray; 2.30 A; A=28-166.
DR   PDB; 3HQI; X-ray; 2.62 A; A/B=28-329.
DR   PDB; 3HQL; X-ray; 1.66 A; A/B=28-166.
DR   PDB; 3HQM; X-ray; 1.74 A; A/B=28-166.
DR   PDB; 3HSV; X-ray; 1.43 A; A/B=28-166.
DR   PDB; 3HTM; X-ray; 2.50 A; A/B/C/D=172-329.
DR   PDB; 3HU6; X-ray; 2.70 A; A/B=28-329.
DR   PDB; 3IVB; X-ray; 1.75 A; A=28-166.
DR   PDB; 3IVQ; X-ray; 2.10 A; A/B=28-166.
DR   PDB; 3IVV; X-ray; 1.25 A; A=28-166.
DR   PDB; 4EOZ; X-ray; 2.40 A; A/C=177-319.
DR   PDB; 4HS2; X-ray; 1.53 A; A=270-374.
DR   PDB; 4J8Z; X-ray; 2.42 A; A/B=169-374.
DR   PDB; 4O1V; X-ray; 2.00 A; A=28-166.
DR   PDBsum; 2CR2; -.
DR   PDBsum; 3HQH; -.
DR   PDBsum; 3HQI; -.
DR   PDBsum; 3HQL; -.
DR   PDBsum; 3HQM; -.
DR   PDBsum; 3HSV; -.
DR   PDBsum; 3HTM; -.
DR   PDBsum; 3HU6; -.
DR   PDBsum; 3IVB; -.
DR   PDBsum; 3IVQ; -.
DR   PDBsum; 3IVV; -.
DR   PDBsum; 4EOZ; -.
DR   PDBsum; 4HS2; -.
DR   PDBsum; 4J8Z; -.
DR   PDBsum; 4O1V; -.
DR   ProteinModelPortal; O43791; -.
DR   SMR; O43791; 28-359.
DR   BioGrid; 113993; 34.
DR   IntAct; O43791; 17.
DR   MINT; MINT-1438409; -.
DR   STRING; 9606.ENSP00000240327; -.
DR   PhosphoSite; O43791; -.
DR   BioMuta; SPOP; -.
DR   MaxQB; O43791; -.
DR   PaxDb; O43791; -.
DR   PRIDE; O43791; -.
DR   DNASU; 8405; -.
DR   Ensembl; ENST00000347630; ENSP00000240327; ENSG00000121067.
DR   Ensembl; ENST00000393328; ENSP00000377001; ENSG00000121067.
DR   Ensembl; ENST00000503676; ENSP00000420908; ENSG00000121067.
DR   Ensembl; ENST00000504102; ENSP00000425905; ENSG00000121067.
DR   GeneID; 8405; -.
DR   KEGG; hsa:8405; -.
DR   UCSC; uc002ipb.3; human.
DR   CTD; 8405; -.
DR   GeneCards; GC17M047676; -.
DR   HGNC; HGNC:11254; SPOP.
DR   HPA; HPA046820; -.
DR   MIM; 602650; gene.
DR   neXtProt; NX_O43791; -.
DR   PharmGKB; PA36084; -.
DR   eggNOG; NOG273048; -.
DR   GeneTree; ENSGT00390000000361; -.
DR   HOGENOM; HOG000231621; -.
DR   HOVERGEN; HBG001393; -.
DR   InParanoid; O43791; -.
DR   KO; K10523; -.
DR   OMA; HAENRQV; -.
DR   OrthoDB; EOG73NG3G; -.
DR   PhylomeDB; O43791; -.
DR   TreeFam; TF313419; -.
DR   BRENDA; 6.3.2.19; 2681.
DR   Reactome; REACT_268718; Hedgehog 'on' state.
DR   SignaLink; O43791; -.
DR   UniPathway; UPA00143; -.
DR   ChiTaRS; SPOP; human.
DR   EvolutionaryTrace; O43791; -.
DR   GeneWiki; SPOP; -.
DR   GenomeRNAi; 8405; -.
DR   NextBio; 31454; -.
DR   PRO; PR:O43791; -.
DR   Proteomes; UP000005640; Chromosome 17.
DR   Bgee; O43791; -.
DR   CleanEx; HS_SPOP; -.
DR   ExpressionAtlas; O43791; baseline and differential.
DR   Genevisible; O43791; HS.
DR   GO; GO:0031463; C:Cul3-RING ubiquitin ligase complex; IDA:UniProtKB.
DR   GO; GO:0016607; C:nuclear speck; IEA:UniProtKB-SubCell.
DR   GO; GO:0005654; C:nucleoplasm; TAS:Reactome.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0031625; F:ubiquitin protein ligase binding; IPI:UniProtKB.
DR   GO; GO:0042593; P:glucose homeostasis; IEA:Ensembl.
DR   GO; GO:0043433; P:negative regulation of sequence-specific DNA binding transcription factor activity; IEA:Ensembl.
DR   GO; GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IEA:Ensembl.
DR   GO; GO:1902237; P:positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway; IEA:Ensembl.
DR   GO; GO:2000676; P:positive regulation of type B pancreatic cell apoptotic process; IEA:Ensembl.
DR   GO; GO:0043161; P:proteasome-mediated ubiquitin-dependent protein catabolic process; IMP:UniProtKB.
DR   GO; GO:0042787; P:protein ubiquitination involved in ubiquitin-dependent protein catabolic process; IEA:Ensembl.
DR   InterPro; IPR000210; BTB/POZ-like.
DR   InterPro; IPR011333; BTB/POZ_fold.
DR   InterPro; IPR013069; BTB_POZ.
DR   InterPro; IPR002083; MATH.
DR   InterPro; IPR008974; TRAF-like.
DR   Pfam; PF00651; BTB; 1.
DR   Pfam; PF00917; MATH; 1.
DR   SMART; SM00225; BTB; 1.
DR   SMART; SM00061; MATH; 1.
DR   SUPFAM; SSF49599; SSF49599; 1.
DR   SUPFAM; SSF54695; SSF54695; 1.
DR   PROSITE; PS50097; BTB; 1.
DR   PROSITE; PS50144; MATH; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Complete proteome; Nucleus; Reference proteome;
KW   Ubl conjugation pathway.
FT   CHAIN         1    374       Speckle-type POZ protein.
FT                                /FTId=PRO_0000191621.
FT   DOMAIN       31    161       MATH. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00129}.
FT   DOMAIN      173    297       BTB. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00037}.
FT   REGION       71    191       Required for nuclear localization.
FT   REGION      123    133       Important for binding substrate proteins.
FT   REGION      186    217       Important for homodimerization.
FT   REGION      297    355       Important for homodimerization.
FT   MUTAGEN      87     87       Y->A: Strongly reduced affinity for
FT                                substrate proteins.
FT                                {ECO:0000269|PubMed:19818708}.
FT   MUTAGEN     123    123       Y->A: Strongly reduced affinity for
FT                                substrate proteins.
FT                                {ECO:0000269|PubMed:19818708}.
FT   MUTAGEN     130    130       D->A: Strongly reduced affinity for
FT                                substrate proteins.
FT                                {ECO:0000269|PubMed:19818708}.
FT   MUTAGEN     131    131       W->A: Strongly reduced affinity for
FT                                substrate proteins.
FT                                {ECO:0000269|PubMed:19818708}.
FT   MUTAGEN     133    133       F->A: Strongly reduced affinity for
FT                                substrate proteins.
FT                                {ECO:0000269|PubMed:19818708}.
FT   MUTAGEN     186    186       L->D: Strongly reduced homodimerization.
FT                                Reduces the activity of the cullin-RING-
FT                                based BCR (BTB-CUL3-RBX1) E3 ubiquitin-
FT                                protein ligase complex.
FT                                {ECO:0000269|PubMed:19818708}.
FT   MUTAGEN     190    190       L->D: Strongly reduced homodimerization.
FT                                Reduces the activity of the cullin-RING-
FT                                based BCR (BTB-CUL3-RBX1) E3 ubiquitin-
FT                                protein ligase complex.
FT                                {ECO:0000269|PubMed:19818708}.
FT   MUTAGEN     193    193       L->D: Strongly reduced homodimerization.
FT                                Reduces the activity of the cullin-RING-
FT                                based BCR (BTB-CUL3-RBX1) E3 ubiquitin-
FT                                protein ligase complex.
FT                                {ECO:0000269|PubMed:19818708}.
FT   MUTAGEN     217    217       I->K: Strongly reduced homodimerization.
FT                                Reduces the activity of the cullin-RING-
FT                                based BCR (BTB-CUL3-RBX1) E3 ubiquitin-
FT                                protein ligase complex.
FT                                {ECO:0000269|PubMed:19818708}.
FT   CONFLICT    239    239       N -> S (in Ref. 3; BAD96309).
FT                                {ECO:0000305}.
FT   STRAND       31     40       {ECO:0000244|PDB:3IVV}.
FT   HELIX        41     43       {ECO:0000244|PDB:3IVV}.
FT   HELIX        45     48       {ECO:0000244|PDB:3IVB}.
FT   STRAND       57     60       {ECO:0000244|PDB:3IVV}.
FT   HELIX        61     63       {ECO:0000244|PDB:3IVV}.
FT   STRAND       65     72       {ECO:0000244|PDB:3IVV}.
FT   HELIX        78     80       {ECO:0000244|PDB:3IVV}.
FT   STRAND       83     92       {ECO:0000244|PDB:3IVV}.
FT   STRAND       94    107       {ECO:0000244|PDB:3IVV}.
FT   STRAND      113    118       {ECO:0000244|PDB:3IVV}.
FT   STRAND      123    126       {ECO:0000244|PDB:3IVV}.
FT   STRAND      130    138       {ECO:0000244|PDB:3IVV}.
FT   HELIX       139    143       {ECO:0000244|PDB:3IVV}.
FT   HELIX       145    147       {ECO:0000244|PDB:3IVV}.
FT   STRAND      148    150       {ECO:0000244|PDB:3HQL}.
FT   HELIX       151    153       {ECO:0000244|PDB:3IVV}.
FT   STRAND      155    163       {ECO:0000244|PDB:3IVV}.
FT   HELIX       186    196       {ECO:0000244|PDB:4EOZ}.
FT   STRAND      202    206       {ECO:0000244|PDB:4EOZ}.
FT   STRAND      209    213       {ECO:0000244|PDB:4EOZ}.
FT   HELIX       215    221       {ECO:0000244|PDB:4EOZ}.
FT   HELIX       223    230       {ECO:0000244|PDB:4EOZ}.
FT   STRAND      231    233       {ECO:0000244|PDB:4EOZ}.
FT   HELIX       234    238       {ECO:0000244|PDB:4EOZ}.
FT   STRAND      240    243       {ECO:0000244|PDB:4EOZ}.
FT   HELIX       248    260       {ECO:0000244|PDB:4EOZ}.
FT   HELIX       266    268       {ECO:0000244|PDB:4EOZ}.
FT   HELIX       270    279       {ECO:0000244|PDB:4EOZ}.
FT   HELIX       283    290       {ECO:0000244|PDB:4EOZ}.
FT   TURN        299    301       {ECO:0000244|PDB:4HS2}.
FT   HELIX       302    311       {ECO:0000244|PDB:4HS2}.
FT   HELIX       315    327       {ECO:0000244|PDB:4HS2}.
FT   HELIX       329    332       {ECO:0000244|PDB:4HS2}.
FT   HELIX       336    344       {ECO:0000244|PDB:4HS2}.
FT   HELIX       346    357       {ECO:0000244|PDB:4HS2}.
SQ   SEQUENCE   374 AA;  42132 MW;  EE5F4C5CF6FD09DC CRC64;
     MSRVPSPPPP AEMSSGPVAE SWCYTQIKVV KFSYMWTINN FSFCREEMGE VIKSSTFSSG
     ANDKLKWCLR VNPKGLDEES KDYLSLYLLL VSCPKSEVRA KFKFSILNAK GEETKAMESQ
     RAYRFVQGKD WGFKKFIRRD FLLDEANGLL PDDKLTLFCE VSVVQDSVNI SGQNTMNMVK
     VPECRLADEL GGLWENSRFT DCCLCVAGQE FQAHKAILAA RSPVFSAMFE HEMEESKKNR
     VEINDVEPEV FKEMMCFIYT GKAPNLDKMA DDLLAAADKY ALERLKVMCE DALCSNLSVE
     NAAEILILAD LHSADQLKTQ AVDFINYHAS DVLETSGWKS MVVSHPHLVA EAYRSLASAQ
     CPFLGPPRKR LKQS
//
